Mass General Brigham AI tool FaceAge identifies rapid facial aging as predictor of lower cancer survival rates

Mass General Brigham study reveals FaceAge AI can predict cancer outcomes by tracking how fast a patient's face ages during medical treatment.

By: AXL Media

Published: Apr 29, 2026, 7:34 AM EDT

Source: Information for this report was sourced from EurekAlert!

The Evolution of Facial Analysis in Clinical Oncology

A research team at Mass General Brigham has developed a deep learning system capable of identifying biological health markers through simple facial photography. The tool, known as FaceAge, was recently evaluated in a study involving 2,279 cancer patients to determine how changes in appearance over the course of treatment reflect internal physiological resilience. By analyzing multiple photos taken at different stages of radiation therapy, the researchers established a metric called the Face Aging Rate. According to Raymond Mak, a radiation oncologist at Mass General Brigham, this technology allows for the near real-time tracking of a patient's health status through non-invasive means. The findings suggest that the rate at which a face appears to age during a medical crisis can serve as a powerful prognostic indicator for survival.

Quantifying Biological Deviation from Chronological Age

The research differentiates between two primary metrics: FaceAge Deviation, which measures how much older or younger a patient looks in a single photo compared to their actual age, and the Face Aging Rate, which tracks the speed of that change over time. In the analyzed cohort, the median results indicated that facial aging in cancer patients outpaced chronological aging by approximately 40%. The study revealed that patients who exhibited accelerated aging between photographs taken at least two years apart had the lowest survival probabilities. This suggests that while a single snapshot offers a baseline of biological wear, the dynamic measurement of aging over an extended interval provides a more stable and reliable prediction of long-term health outcomes.

Integrating Artificial Intelligence into Personalized Care

The application of FaceAge could fundamentally alter how oncologists approach patient counseling and follow-up schedules. By identifying individuals whose biological age is advancing rapidly, medical teams can refine treatment plans and adjust the intensity of clinical monitoring. Hugo Aerts, director of the Artificial Intelligence in Medicine program at Mass General Brigham, noted that the tool offers a cost-effective alternative to traditional, invasive biomarkers. The deep learning models used in the study were trained to detect subtle nuances in facial structure and skin quality that correlate with syste...